Vetflurane 1000 mg/g Inhalation Vapour, Liquid

Nchi: Uingereza

Lugha: Kiingereza

Chanzo: VMD (Veterinary Medicines Directorate)

Viambatanisho vya kazi:

Isoflurane

Inapatikana kutoka:

Virbac

ATC kanuni:

QN01AB06

INN (Jina la Kimataifa):

Isoflurane

Dawa fomu:

Inhalation vapour, liquid

Dawa ya aina:

POM-V - Prescription Only Medicine – Veterinarian

Kundi la matibabu:

Cats, Chinchilla, Dogs, Ferrets, Gerbil, Guinea Pig, Hamster, Horses, Mouse, Ornamental Birds, Rat, Reptiles

Eneo la matibabu:

Neurological Agent general anaesthetic

Idhini hali ya:

Authorized

Idhini ya tarehe:

2010-09-16

Tabia za bidhaa

Revised: February 2016
AN: 01092/2014
Page 1 of 9
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Vetflurane 1000 mg/g Inhalation vapour, liquid
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each millilitre contains:
Active substance:
Isoflurane 1000 mg/g.
The veterinary medicinal product contains no excipients.
3.
PHARMACEUTICAL FORM
Inhalation vapour, liquid
Clear, colourless liquid
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses, dogs, cats, ornamental birds, reptiles, rats, mice, hamsters,
chinchillas, gerbils,
guinea pigs and ferrets.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Induction and maintenance of general anaesthesia.
4.3
CONTRAINDICATIONS
Do not use in case of known susceptibility to malignant hyperthermia.
Do not use in cases of known hypersensitivity to isoflurane or to
other halogenated agents.
4.4
SPECIAL WARNINGS
The metabolism of birds, and to an extent small mammals, is affected
more profoundly by
decreases in body temperature, due to high surface area to body weight
ratio. Drug
metabolism in reptiles is slow and highly dependent upon environmental
temperature.
The absorption, distribution and elimination of isoflurane are rapid,
and it is eliminated
largely unchanged via the lungs. These characteristics may make it
suitable for groups of
patients including the young or old, or those with impaired hepatic,
renal or cardiac
function, however anaesthetic protocols should be decided on a case by
case basis.
Revised: February 2016
AN: 01092/2014
Page 2 of 9
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Isoflurane has little or no analgesic properties. Adequate analgesia
should always be given
before surgery. The analgesic requirements of the patient should be
considered before
general anaesthesia is ended.
The use of the product in patients with cardiac disease should be
considered only after a
risk/ benefit assessment by the veterinarian.
It’s important to monitor breathing and pulse for the frequency and
its features. It’s